Investors may begin to purchase shares in the GPT Healthcare IPO tomorrow, February 22. ‘ILS Hospitals’ is the name of the group of medium-sized hospitals operated by GPT Healthcare Ltd. Their primary concentration is on advanced care, but they provide a broad spectrum of healthcare services.
As stated in the Red Herring Prospectus (RHP), the business provides a wide range of medical services in more than 35 specialty areas. Common medical care, laparoscopic surgery, diabetes treatments, kidney care (including transplants), care for expectant mothers and women’s health, critical care, stomach and digestive system care, bone and joint care (including replacement surgeries), heart care through specialized procedures, brain and nerve care, care for children, and specialized care for newborn babies are among these.
The company ran four hospitals with different specializations in medicine as of September 30, 2023. With a combined total of 561 beds, these hospitals are situated in West Bengal’s Howrah, Dum Dum, Salt Lake, and Agartala.
As per the Red Herring Prospectus (RHP), the following companies are in the same industry as us: Yatharth Hospital & Trauma Care Services Limited (P/E ratio: 37.66), Kovai Medical Center & Hospital Limited (P/E ratio: 29.93), Global Health Limited (P/E ratio: 90.29), Krishna Institute of Medical Sciences Limited (P/E ratio: 49.51), Jupiter Life Line Hospitals Limited (P/E ratio: 81.73), and Shalby Limited (P/E ratio: 49.01).
The promoters, or proprietors, of the company are Dwarika Prasad Tantia, Dr. Om Tantia, Shree Gopal Tantia, and GPT Sons Private Limited. Collectively, these promoters hold 53,805,600 shares as of the date of this Red Herring Prospectus (February 15, 2024), accounting for 67.34% of all equity shares issued by the business.
GPT Healthcare Limited saw a 6.37% decline in profit after tax (PAT) between March 31, 2022, and March 31, 2023, despite a 7.11% growth in revenue.
Insights of GPT Healthcare IPO:
Here’s a breakdown of the details related to the GPT Healthcare IPO:
- IPO Date: The GPT Healthcare IPO opens for subscription on Thursday, February 22, and closes on Monday, February 26.
- Price Band: The price band for the GPT IPO is set between ₹177 to ₹186 per equity share of face value of ₹10.
- Lot Size: The lot size for the GPT IPO is 80 equity shares, and thereafter in multiples of 80 equity shares.
- Anchor Investors: On Wednesday, February 21, allocation to anchor investors for the GPT Healthcare IPO is planned.
- IPO Details: The GPT Healthcare IPO is worth ₹525.14 crore. It comprises a fresh issue of ₹40 crore and an offer-for-sale (OFS) of 26,082,786 equity shares of ₹10 each, aggregating up to ₹485.14 crore by the investor selling shareholder, BanyanTree Growth Capital II, LLC.
- Objectives: The net proceeds from the IPO will be used for general corporate purposes and full or partial repayment of existing loans obtained from banks and financial institutions.
- Listing Date and Allotment: Tentatively, the basis of allotment of shares will be finalized on Tuesday, February 27. Refunds will be initiated on Wednesday, February 28, and shares will be credited to the demat accounts of allottees on the same day.
- Lead Manager and Registrar: JM Financial Limited is the book running lead manager for the GPT Healthcare IPO, and Link Intime India Private Ltd. is the issue’s registrar.
- Reservation: Not more than 50% of the shares in the public issue are reserved for qualified institutional buyers (QIB), not less than 15% for non-institutional investors (NII), and not less than 35% of the offer is reserved for retail investors.
- GMP Today: The grey market premium (GMP) for GPT IPO was ₹0, indicating that shares were trading at their issue price of ₹186 with no premium or discount in the grey market according to investorgain.com.
